Another study suggested that overexpression of CAPN4 was an independent prognostic factor in patients with NSCLC, and could enhance the invasive potential of lung cancer cells by upregulating the expression of matrix metalloproteinase 223. The gene discussed is CAPNS1; the disease is lung cancer.